NIH-funded research NIH-funded research

Helping people recover after stroke by boosting brain cell energy

Official title: Enhanced Mitochondrial Function Increases Effectiveness of Post-Stroke Rehabilitation

Funded at Southern Arizona VA Health Care System · NIH-11206889 · Data updated 2026-11-12

The team is seeing if a drug that clears harmful fat debris and restores cell energy can limit brain damage and improve movement recovery after stroke.

More Stroke research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSouthern Arizona VA Health Care System
NIH-funded
Lab location1 site (Tucson, United States)
Project startSeptember 1, 2019
Project endOctober 31, 2028
Funding year2025
NIH project number5I01RX003224-06
Project IDNIH-11206889 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for eventual human testing would be people who recently had an ischemic stroke and are undergoing motor rehabilitation for arm or leg weakness.

Less likely to help

People with non-ischemic (e.g., hemorrhagic) strokes or whose injury is many years old may be less likely to benefit from this specific approach.

What this research studies

If you had a stroke, this research is testing a medicine called HPβCD that helps immune cells clean up myelin-derived fat debris and restore their mitochondria (the cell's power plants). In mice, researchers give the drug after stroke and combine it with motor rehabilitation to see whether it reduces tissue loss and speeds recovery of movement and memory. They track brain tissue, inflammation, mitochondrial health in immune cells, and behavior to measure benefit. The work is currently done in an animal model at the Southern Arizona VA with the goal of informing future treatments for people who have had strokes.

Why it matters

Potential benefit: If successful, this approach could reduce long-term brain damage after stroke and make rehabilitative therapy more effective for regaining movement and memory.

How similar studies have gone: Preclinical studies in mice from the same group have shown promising results, but this specific treatment approach has not yet been tested in people.

Where this research is happening

  • Southern Arizona VA Health Care System
    Tucson, United States
    Active

Researchers

  • Principal investigator: Schnellmann, Rick G — Southern Arizona VA Health Care System
  • Study coordinator: Schnellmann, Rick G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.